Invesco Biotechnology & Genome ETF
PBE
PBE
82 hedge funds and large institutions have $129M invested in Invesco Biotechnology & Genome ETF in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
Holders
82
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.45M | |
| 2 | +$718K | |
| 3 | +$607K | |
| 4 |
Millennium Management
New York
|
+$596K |
| 5 |
BWP
Baldwin Wealth Partners
Marion,
Massachusetts
|
+$521K |
Top Sellers
| 1 | -$2.95M | |
| 2 | -$896K | |
| 3 | -$568K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$474K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$427K |